Speakers

His seminal discoveries in these areas have led to the invention of numerous commercially important technologies for the discovery, design, delivery, and manufacture of human therapeutic proteins and vaccines. He is an elected fellow of the American Association for the Advancement of Science (AAAS), the American Institute for Medical and Biological Engineering (AIMBE), and the American Academy of Microbiology (AAM), and a recipient of many honorific distinctions and prestigious awards including the Marvin J. Johnson Award from the American Chemical Society BIOT Division, the Charles Thom Award from the Society for Industrial Microbiology and Biotechnology, an NSF CAREER Award, and Young Investigator Awards from the ACS BIOT Division, Beckman Foundation, Biochemical Engineering Journal, and Office of Naval Research (ONR). He was also named to City&State New York’s “Life Sciences Power 50”, which recognizes individuals driving New York’s biotech sector growth, and selected to the IDA/DARPA Defense Science Study Group and the National Academies Committee on Innovative Technologies to Advance Pharmaceutical Manufacturing. He has published over 170 papers and serves/served on editorial boards for 16 journals including as Chief Editor for the Glycobiology Section of Frontiers in Molecular Biosciences and Co-Editor-in-Chief of Applied Biochemistry and Biotechnology. He holds 54 granted US and Foreign Patents and more than 40 pending patents (provisional and non-provisional), with 61 of these having been licensed to companies. He is also co-founder of 8 startup companies, one of which–SwiftScale Biologics–was acquired in 2021 by National Resilience.